HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma.

Abstract
Dual-specificity phosphatase 10 (DUSP10) correlates with inflammation, cytokine secretion, cell proliferation, survival, and apoptosis. However, its role in glioma is unclear. Herein, we sought to examine the expression and the underlying carcinogenic mechanisms of DUSP10 action in glioma. DUSP10 expression in glioma was significantly higher than that in normal brain tissues. High DUSP10 expression indicated adverse clinical outcomes in glioma patients. Increased DUSP10 expression correlated significantly with clinical features in glioma. Univariate Cox analysis showed that high DUSP10 expression was a potential independent marker of poor prognosis in glioma. Furthermore, DUSP10 expression in glioma correlated negatively with its DNA methylation levels. DNA methylation level of DUSP10 also correlated negatively with poor prognosis in glioma. More importantly, DUSP10 expression correlated positively with the infiltration of B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and dendritic cells in glioma. Gene set enrichment analysis (GSEA) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis confirmed that DUSP10 participated in signaling pathways involved in focal adhesion, TNF cascade, Th17 cell differentiation, and NF-kappa B cascade. Finally, we uncovered that DUSP10 was dramatically upregulated in glioblastoma (GBM) cells and that the knockdown of DUSP10 inhibited glioma cell proliferation and migration. Our findings suggested that DUSP10 may serve as a potential prognostic biomarker in glioma.
AuthorsFang Zhou, Lingfeng Zeng, Xi Chen, Fan Zhou, Zhen Zhang, Yixiao Yuan, Heping Wang, Huayi Yao, Jintao Tian, Xujie Liu, Jinxi Zhao, Xiaobin Huang, Jun Pu, William C Cho, Jianxiong Cao, Xiulin Jiang
JournalFrontiers in oncology (Front Oncol) Vol. 12 Pg. 1050756 ( 2022) ISSN: 2234-943X [Print] Switzerland
PMID36713584 (Publication Type: Journal Article)
CopyrightCopyright © 2023 Zhou, Zeng, Chen, Zhou, Zhang, Yuan, Wang, Yao, Tian, Liu, Zhao, Huang, Pu, Cho, Cao and Jiang.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: